Predicting Survival in Patients with Malignant Pleural Mesothelioma
Researchers found a new way of predicting survival in malignant pleural mesothelioma patients. The prognostic model takes information from the…
The RARECARE Project: An International Network Includes Mesothelioma
The RARECARE Project is a network of international clinicians who support rare tumor patients. This includes malignant mesothelioma, the asbestos-caused…
New Tool Measures Past Exposure to Asbestos
A new Italian study supports the most reliable tool for determining past exposure to asbestos. The study has confirmed what…
Major Effect of COVID-19 on Mesothelioma Patient Survival in Italy
The COVID‐19 pandemic had a major effect on some mesothelioma patients in Italy. A new study in Medical & Clinical…
Chemotherapy | Diagnosis | Research | Surgery | Treatments | Updates
Localized Mesothelioma Successfully Treated with Chemotherapy and Surgery
A patient with a rare, localized malignant pleural mesothelioma has been successfully treated. The patient received chemotherapy and surgery and…
Mesothelioma Multidisciplinary Team Improves Patient Outcomes
Oxford University Hospital found that a multidisciplinary team is best in mesothelioma care. This treatment approach includes many doctors who…
Earlier Mesothelioma Diagnosis with Machine Learning Model
A new machine learning model can diagnose mesothelioma better than any current model. The model provides new hope for early…
Prognostic Factors Forecast the Future for Women with Mesothelioma
A new study in the World Journal of Surgical Oncology examines mesothelioma prognostic factors. Prognostic factors are measurable traits that…
Mesothelioma and the Promising New Hippo Biomarker
A new review in Targeted Oncology looks at a promising new Hippo biomarker in malignant pleural mesothelioma. The new biomarker…
Easing the Painful Symptoms of Malignant Pleural Mesothelioma
Malignant pleural mesothelioma is an aggressive and rare cancer. There is new hope for reducing the painful symptoms of malignant…